| Bioactivity | Emraclidine (CVL-231) is a muscarinic M4 receptor positive allosteric modulator (WO2018002760, compound 11). Emraclidine can be used for the research of neurological diseases[1]. | ||||||||||||
| Target | Muscarinic M4 Receptor | ||||||||||||
| Invitro | Emraclidine is a muscarinic M4 receptor positive allosteric modulator[1]. | ||||||||||||
| Name | Emraclidine | ||||||||||||
| CAS | 2170722-84-4 | ||||||||||||
| Formula | C20H21F3N4O | ||||||||||||
| Molar Mass | 390.40 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. WO2018002760 |